Bio-Connect

ULBP2 antibody [7F33]

GTX53048
GeneTex
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetULBP2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ULBP2 antibody [7F33]
  • Delivery Days Customer
    9
  • Application Supplier Note
    FACS: 1:50 - 1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    7F33
  • Concentration
    500 ug/ml
  • Conjugate
    Unconjugated
  • Gene ID80328
  • Target name
    ULBP2
  • Target description
    UL16 binding protein 2
  • Target synonyms
    ALCAN-alpha; N2DL2; NKG2D ligand 2; NKG2DL2; RAET1H; RAET1L; retinoic acid early transcript 1H; retinoic acid early transcript 1L; UL16-binding protein 2
  • Host
    Mouse
  • Isotype
    IgG2
  • Protein IDQ9BZM5
  • Protein Name
    UL16-binding protein 2
  • Scientific Description
    This gene encodes a major histocompatibility complex (MHC) class I-related molecule that binds to the NKG2D receptor on natural killer (NK) cells to trigger release of multiple cytokines and chemokines that in turn contribute to the recruitment and activation of NK cells. The encoded protein undergoes further processing to generate the mature protein that is either anchored to membrane via a glycosylphosphatidylinositol moiety, or secreted. Many malignant cells secrete the encoded protein to evade immunosurveillance by NK cells. This gene is located in a cluster of multiple MHC class I-related genes on chromosome 6. [provided by RefSeq, Jul 2015]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells. Shen JZ et al., 2021 Jan 21, Cell
    Read more